• Протек
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 2
    LEADERSHIP
    THROUGH PARTNERSHIP
  • Протек 4
    LEADERSHIP
    THROUGH PARTNERSHIP

CV PROTEK became the leader of pharmaceutical distributors rating in the 1 half-year 2017

According to the results of the 1 half-year 2017, CV PROTEK came in top place of the Russian major distributors rating prepared by analytical company IMS Health.

According to the results of the 1 half-year 2017, combined share of the major distributors in the pharmaceutical direct sales market amounted to 67%. Compared to the 1 half-year 2016, this index increased by 3%. According to the results of 1 half-year 2017, combined share of three major distributors (CV PROTEK, Katren, Puls) amounted to 46.75 %, 17.9% thereof accounts for CV PROTEK.

CV PROTEK took the leading position in pharmaceutical distributors rating for gross sales and commercial sales volume in the Quarter 1-2, 2017.

Rating of the major distributors* in the pharmaceutical direct sales market (including preferential provision of medicines) Quarter 1-2, 2017

 

Distributor

 Pharmaceutical direct sales market share, % 

 Position per gross sales, Quarter 1-2, 2017 

Quarter 1-2, 2017

Quarter 1-2, 2016

 

1

CV PROTEK

17.9%

17.6%

1

2

Katren

15.2%

17.0%

2

3

Puls

13.6%

11.6%

3

4

R- Farm

4.9%

4.3%

4

5

Farmkomplekt

4.5%

3.7%

5

6

BSS

3.5%

4.3%

6

7

Grand Capital

2.7%

0.5%

7

8

Profitmed

1.8%

2.0%

8

9

Irvin 2

1.5%

1.3%

10

10

Evroservice

1.4%

1.7%

-

Total

67.0%

64.0%

 

*prepared based on the data provided by the distributors participating in the rating


Upon results of 9 months of the year 2017 ProApteka is the leader of pharmacy unions

According to the analysts’ data, the union share at pharmaceutical market amounted to 3.63%.  more...

CV PROTEK became the leader of pharmaceutical distributors rating for 9 months 2017

Upon results of 1-3 quarter 2017, сombined share of three major distributors amounted to 48.5 %, 18% thereof ac... more...

CV PROTEK launched My Health affordable care initiative

CV PROTEK launched My Health affordable care initiative

For project members the cost of pharmacological therapy drastically subsides due to sizable discounts for a wide rang... more...